Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
689
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy

Alice Di Roccoa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0985-9623View further author information
ORCID Icon,
Antonio Cuneob Department of Hematology, S. Anna Hospital, University of Ferrara, Ferrara, ItalyView further author information
,
Arianna Di Roccoc Department of Public Health and Infectious Diseases, Sapienza University, Rome, ItalyView further author information
,
Francesco Merlid Hematology, AUSLL/IRCCS Santa Maria Nuova Hospital, Reggio Emilia, ItalyView further author information
,
Giulia De Lucaa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Luigi Petruccia Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Michela Ansuinellia Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
,
Domenico Pennad Hematology, AUSLL/IRCCS Santa Maria Nuova Hospital, Reggio Emilia, Italy;e Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyView further author information
,
Francesco Rotondob Department of Hematology, S. Anna Hospital, University of Ferrara, Ferrara, ItalyView further author information
,
Gian Matteo Rigolinb Department of Hematology, S. Anna Hospital, University of Ferrara, Ferrara, ItalyView further author information
,
Mariateresa Giaimof Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, ItalyView further author information
,
Francesca Ref Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, ItalyView further author information
,
Alessio Farcomenig Department of Economics and Finance, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-7104-5826View further author information
ORCID Icon,
Maurizio Martellia Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
&
Robin Foàa Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ItalyView further author information
 show all
Pages 828-836 | Received 27 Jul 2020, Accepted 05 Nov 2020, Published online: 04 Dec 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Salvatore Perrone, Paolo Lopedote, Mario Levis, Alice Di Rocco & Stephen Douglas Smith. (2022) Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert Review of Hematology 15:3, pages 215-232.
Read now

Articles from other publishers (10)

Miguel Á. Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, Barthold Deiters, Claudio Jommi, Reinhard Marks, Catherine Rioufol, Juan M. Sancho Cia, Armando Santoro & Eva M. Wagner-Drouet. (2023) Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries. Frontiers in Medicine 10.
Crossref
Xinping Cao, Xin Jin, Xiaomei Zhang, Paudel Utsav, Yi Zhang, Ruiting Guo, Wenyi Lu & Mingfeng Zhao. (2023) Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. Current Treatment Options in Oncology 24:3, pages 184-211.
Crossref
Georg Hopfinger, Bernhard Rupp & Richard Greil. (2023) Barriers to patient access of CAR T cell therapies in Austria. memo - Magazine of European Medical Oncology 16:1, pages 79-90.
Crossref
María Elena Cabrera, Camila Peña, Pilar Leon, Vivianne Lois, Hernán Rojas, Valeska Vega, Alvaro Pizarro, Susana Calderon, Christine Rojas, Augusto Aspillaga, M. Luisa Gonzalez, Marvila Intriago, Bernardita Rojas, Cecilia Hales, Jacqueline Oliva, Mónica Romero, Marisa Capurro & Jorge J. Castillo. (2022) Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System. JCO Global Oncology:8.
Crossref
Francesca Lorraine Wei Inng Lim, Chen Yunxin, Feng‐Ju Huang & William Ying Khee Hwang. (2022) A unique hub‐and‐spoke model to optimize patient management in lymphoma using novel CAR‐T cell therapy in Southeast and South Asia. Hematological Oncology 40:S1, pages 4-12.
Crossref
Francesca Lorraine Wei Inng Lim, Chen Yunxin, Feng‐Ju Huang & William Ying Khee Hwang. (2022) A unique hub‐and‐spoke model to optimize patient management in lymphoma using novel chimeric antigen receptor‐T cell therapy in Southeast and South Asia. Hematological Oncology.
Crossref
Claudio Jommi, Stefania Bramanti, Marcello Pani, Alessandro Ghirardini & Armando Santoro. (2022) CAR T-Cell Therapies in Italy: Patient Access Barriers and Recommendations for Health System Solutions. Frontiers in Pharmacology 13.
Crossref
Jean Galtier, Laetitia Vercellino, Loic Chartier, Pierre Olivier, Claire Tabouret-Viaud, Charles Mesguich, Roberta Di Blasi, Amandine Durand, Léo Raffy, François-Xavier Gros, Isabelle Madelaine, Veronique Meignin, Miryam Mebarki, Marie-Thérèse Rubio, Pierre Feugier, Olivier Casasnovas, Michel Meignan & Catherine Thieblemont. (2022) Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells. Haematologica 108:1, pages 171-180.
Crossref
Lars Kurch, Thomas W. Georgi, Astrid Monecke, Daniel Seehofer, Gudrun Borte, Osama Sabri, Regine Kluge, Simone Heyn, Matthias Pierer, Uwe Platzbecker & Sabine Kayser. (2022) Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Frontiers in Oncology 11.
Crossref
Marie Maerevoet, Josee M. Zijlstra, George Follows, Rene-Olivier Casasnovas, J. S. P. Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Xiwen Ma, Kelly Corona, Kamal Chamoun, Jatin Shah, Sharon Shacham, Michael G. Kauffman & Miguel Canales. (2021) Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study. Journal of Hematology & Oncology 14:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.